JF
PTCT icon

Jump Financial’s PTC Therapeutics PTCT Stock Holding History

Jump Financial’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-51,606
Closed -$2.52M – 2126
2025
Q2 		$2.52M Buy
+51,606
New +$2.45M 0.03% 639
2025
Q1 		– Sell
-62,809
Closed -$2.84M – 1934
2024
Q4 		$2.84M Buy
+62,809
New +$2.69M 0.06% 411
2024
Q3 		– Sell
-73,088
Closed -$2.24M – 2030
2024
Q2 		$2.24M Buy
73,088
+35,141
+93% +$1.14M 0.04% 501
2024
Q1 		$1.1M Buy
37,947
+11,691
+45% +$327K 0.03% 751
2023
Q4 		$724K Buy
26,256
+10,846
+70% +$248K 0.02% 880
2023
Q3 		$345K Buy
15,410
+9,494
+160% +$353K 0.01% 1226
2023
Q2 		$241K Buy
+5,916
New +$289K 0.01% 1426
2022
Q4 		– Sell
-67,762
Closed -$3.4M – 1947
2022
Q3 		$3.4M Sell
67,762
-38
-0.1% -$1.86K 0.13% 226
2022
Q2 		$2.72M Buy
67,800
+60,200
+792% +$2.11M 0.12% 236
2022
Q1 		$284K Buy
+7,600
New +$293K 0.01% 1094

Other funds holding PTCT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jump Financial's PTCT Position: Q3 2025 in Review

Jump Financial sold out of PTC Therapeutics (PTCT) in Q3 2025, closing a stake of 51,606 shares — an estimated $2.52M sold.

Jump Financial first reported a position in PTCT in Q1 2022 and held it in 10 quarters. The position peaked at $3.4M in Q3 2022. 293 funds tracked by Wall St. Rank hold PTCT as of Q3 2025.

  • Jump Financial reported no remaining PTC Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Jump Financial sold 51,606 PTC Therapeutics shares in Q3 2025, an estimated $2.52M.
  • Jump Financial first reported a position in PTC Therapeutics in Q1 2022 and held it in 10 quarters.
  • Jump Financial's PTC Therapeutics position peaked at $3.4M in Q3 2022.
  • 293 funds tracked by Wall St. Rank held PTC Therapeutics as of Q3 2025.

Based on Jump Financial's 13F filing for Q3 2025, filed 13 Nov 2025.